Finance

Lists
ELDN:NASDAQ
Eledon Pharmaceuticals Inc
$2.62
-1.13%
(-0.030) 1D
$2.71
+3.44% (+0.090)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELDN...
Open
$2.67
High
$2.68
Low
$2.57
Mkt. cap
212.90M
Avg. vol.
911.04K
Volume
828.99K
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.96
Beta
0.93
Shares outstanding
81.26M
No. of employees
33
Open
$2.67
High
$2.68
Low
$2.57
Mkt. cap
212.90M
Avg. vol.
911.04K
Volume
828.99K
52-wk high
$4.60
52-wk low
$1.36
EPS
-$0.96
Beta
0.93
Shares outstanding
81.26M
No. of employees
33
News stories
From web sources and news partners
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteeledon.com
Analyst ratings
Based on 4 analysts giving stock ratings to ELDN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ELDN in the last 3 months.
Highest
Current $2.62
$12.00 (+358.02%)
Average
$9.50 (+262.60%)
Lowest
$8.00 (+205.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
$10.00
+281.7%
09/04/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$8.00
+205.3%
09/03/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$8.00
+205.3%
08/13/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$12.00
+358%
07/21/2026
Vamil Divan
Guggenheim
Buy
Maintained
$8.00
+205.3%
03/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.97M
17.49M
17.20M
18.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.10M
3.99M
3.98M
4.64M
Operating expense
19.07M
21.48M
21.18M
22.87M
Total operating expenses
19.07M
21.48M
21.18M
22.87M
Operating income
-19.07M
-21.48M
-21.18M
-22.87M
Other non operating income
1.61M
11.07M
-17.84M
-8.76M
EBT including unusual items
-17.46M
-10.41M
-39.02M
-31.63M
EBT excluding unusual items
-17.46M
-10.41M
-39.02M
-31.63M
Income tax expense
-
35.00K
-
-
Effective tax rate
-
-0.34%
-
-
Other operating expenses
-
-
-
-
Net income
-17.46M
-10.45M
-39.02M
-31.63M
Net profit margin
-
-
-
-
Earnings per share
-0.21
-0.10
-0.33
-0.27
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps